LYNDIBULIN Trademark

Trademark Overview

On Thursday, September 13, 2007, a trademark application was filed for LYNDIBULIN with the United States Patent and Trademark Office. The USPTO has given the LYNDIBULIN trademark a serial number of 77278636. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, June 27, 2011. This trademark is owned by Ziopharm Oncology, Inc.. The LYNDIBULIN trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceuticals for the treatment of cancer
lyndibulin

General Information

Serial Number77278636
Word MarkLYNDIBULIN
Filing DateThursday, September 13, 2007
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, June 27, 2011
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, March 4, 2008

Trademark Statements

Goods and ServicesPharmaceuticals for the treatment of cancer

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, September 18, 2007
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameZiopharm Oncology, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressBoston, MA 02129
Party NameZiopharm Oncology, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressBoston, MA 02129

Trademark Events

Event DateEvent Description
Monday, June 27, 2011ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, June 27, 2011ABANDONMENT - NO USE STATEMENT FILED
Saturday, November 27, 2010NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, November 26, 2010EXTENSION 5 GRANTED
Wednesday, November 24, 2010EXTENSION 5 FILED
Wednesday, November 24, 2010TEAS EXTENSION RECEIVED
Thursday, October 14, 2010TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, May 18, 2010NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, May 17, 2010EXTENSION 4 GRANTED
Wednesday, May 12, 2010EXTENSION 4 FILED
Wednesday, May 12, 2010TEAS EXTENSION RECEIVED
Friday, November 20, 2009EXTENSION 3 GRANTED
Wednesday, November 18, 2009EXTENSION 3 FILED
Wednesday, November 18, 2009TEAS EXTENSION RECEIVED
Monday, June 1, 2009EXTENSION 2 GRANTED
Tuesday, May 12, 2009EXTENSION 2 FILED
Monday, June 1, 2009CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, May 12, 2009TEAS EXTENSION RECEIVED
Tuesday, November 18, 2008EXTENSION 1 GRANTED
Tuesday, November 18, 2008EXTENSION 1 FILED
Tuesday, November 18, 2008TEAS EXTENSION RECEIVED
Tuesday, May 27, 2008NOA MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, March 4, 2008PUBLISHED FOR OPPOSITION
Wednesday, February 13, 2008NOTICE OF PUBLICATION
Tuesday, January 29, 2008LAW OFFICE PUBLICATION REVIEW COMPLETED
Tuesday, January 29, 2008ASSIGNED TO LIE
Monday, December 17, 2007APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, December 17, 2007ASSIGNED TO EXAMINER
Tuesday, September 18, 2007NEW APPLICATION ENTERED IN TRAM

Related Keywords

lyndibulin cancer treatment pharmaceuticals